Related Experiment Video
Updated: Aug 21, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Determinants of coronary artery calcification in diabetics with and without nephropathy
Rajnish Mehrotra1, Matthew Budoff, Peter Christenson
1Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California 90502, USA. rmehrotra@labiomed.org
Insights
Coronary artery calcification in diabetic kidney disease is linked to hypertension, not mineral metabolism issues. This suggests hypertension management may reduce calcification in early diabetic kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Coronary artery calcification (CAC) in diabetes mellitus correlates with atherosclerosis.
- Disordered mineral metabolism contributes to vascular calcification in end-stage renal disease (ESRD).
Purpose of the Study:
- To determine the roles of accelerated atherosclerosis and disordered mineral metabolism in CAC among patients with chronic kidney disease (CKD).
Main Methods:
- A pilot study of 90 patients with type 2 diabetes mellitus (30 normoalbuminuria, 60 with diabetic nephropathy [DN]).
- Evaluated CAC prevalence and severity, and four measures of mineral metabolism.
- Assessed the impact of hypertension severity.
Main Results:
- CAC was significantly more prevalent and severe in patients with DN compared to diabetic controls.
- No correlation was found between mineral metabolism markers and CAC.
- Hypertension severity, indicated by antihypertensive medication use, explained the differences in CAC burden.
Conclusions:
- In predialysis patients with DN, high CAC burden is likely independent of disordered mineral metabolism, unlike in ESRD.
- Hypertension severity is a probable intervention target for reducing CAC in early diabetic CKD.
Background:
In the general population, including those with diabetes mellitus, coronary artery calcification (CAC) correlates with atherosclerotic plaque burden. On the other hand, accumulating evidence suggests that disordered mineral metabolism significantly contributes to the vascular calcification in individuals with end-stage renal disease (ESRD).
Methods:
In order to determine the relative contribution of accelerated atherosclerosis and disordered mineral metabolism to CAC in chronic kidney disease, a pilot study of 90 patients with type 2 diabetes mellitus was done [age, 40-65 years; normoalbuminuria, N= 30; diabetic nephropathy (DN), N= 60].
Results:
CAC was more prevalent and severe among individuals with DN compared to diabetic controls (odds ratio for prevalence 8.1, 95% CI 2.3-28.5; median scores, 66 vs. 4, P < 0.001). None of the 4 measures of disordered mineral metabolism evaluated in this study (serum calcium, phosphorus, parathyroid hormone, and 1,25 di-hydroxy vitamin D levels) correlated with the prevalence or severity of CAC, or accounted for the differences seen between DN and diabetic controls. On the other hand, the difference in the severity of hypertension (number of antihypertensive medications) appeared to account for the differences in CAC burden seen between DN and diabetic controls.
Conclusion:
This first such study of nondialyzed individuals with DN suggests that, unlike ESRD patients, the high CAC burden seen at earlier stages of diabetic chronic kidney disease is probably unrelated to disordered mineral metabolism. The relationship between the severity of hypertension and CAC burden provides a probable target for intervention in the predialysis phase of DN.
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetic Nephropathy
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Chronic Kidney Disease I: Introduction

